Pharmacy-related research is flourishing at UB, thanks to the cutting-edge, multidisciplinary initiatives taking place in the School of Pharmacy and Pharmaceutical Sciences (SoPPS). Research endeavors are diverse, covering clinical and bench research areas such as pharmacoeconomics, protein therapeutics, and HIV/AIDS. Our reputation for research is global in scale, due in part to UB's overarching support for emerging research areas as well as integration with community partners. Visit these links for more information:
Read here to learn more about recent news-making SoPPS research developments:
International AIDS Program
New funding for an innovative University at Buffalo program that trains Zimbabwe's clinician scientists and translational pharmacologists will bring additional health care professionals and researchers to Buffalo to be trained to fight the war on AIDS in Zimbabwe. UB's HIV Clinical Pharmacology Research Program in SoPPS and its program with the University of Zimbabwe has received a $1.5 million National Institutes of Health Fogarty International Center grant Read more about this program:
Neurologists at UB are beginning a research study that could overturn the prevailing wisdom on the cause of multiple sclerosis (MS). The researchers will test the possibility that the symptoms of MS result from narrowing of the primary veins outside the skull, a condition called "chronic cerebrospinal venous insufficiency," or CCSVI. Murali Ramanathan, Ph.D., Professor in the Department of Pharmaceutical Sciences, will analyze blood samples for proteins and soluble factors associated with central nervous system injury. He also will be looking for other factors of interest in MS research, such as vitamin D metabolites and cigarette smoking, which have been linked to increased risk for developing MS as well as MS disease progression.
Pharmacokinetics and Pharmacodynamics
UB SoPPs is the birthplace of the fields of research devoted to Pharmacokinetics, what the body does to a drug and Pharmacodynamics, what the drug does to the body. These foundational principles were developed at UB School of Pharmacy and Pharmaceutical Sciences and the school continues to be the international leader in the seminal and guiding principles of PK/PD. William Jusko, PhD, Chair of the Department of Pharmaceutical Sciences, a world leader in PK/PD, and the most cited researcher within the American Association of Pharmaceutical Sciences (AAPS), was recently interviewed by the AAPS as part of their Distinguished Pharmaceutical Scientist Video Series. Jusko Video
Center for Protein Therapeutics
Pharmaceutical researchers at UB have joined forces with scientists from several of the world's largest pharmaceutical companies to tackle fundamental research questions that need to be answered to advance development of promising protein-based drugs. Their research will be carried out in the Center for Protein Therapeutics, headquartered in UB's New York State Center of Excellence in Bioinformatics and Life Sciences on the Buffalo Niagara Medical Campus with additional facilities also available within SoPPS. The Center will conduct basic research and will train the scientists needed to build an intellectual infrastructure in this developing field.
Center of Excellence in Bioinformatics and Life Sciences
UB SoPPS is proud of the integration of our research and the resulting partnerships we have with the New York State Center of Excellence (CoE) in Bioinformatics and Life Sciences. The New York State Center of Excellence in Bioinformatics and Life Sciences studies the mechanistic processes involved in human disease with the goal of developing diagnostic tools, therapeutic interventions and treatments to improve the health and well being of the population. Our integrations with the Center span research in pharmacy practice and the pharmaceutical sciences. Learn more about the Partnership with Center of Excellence in Bioinformatics and Life Sciences.